<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17636" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Antacids</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salisbury</surname>
            <given-names>Blake H.</given-names>
          </name>
          <aff>MSUCHM - Ascension Providence</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Terrell</surname>
            <given-names>Jamie M.</given-names>
          </name>
          <aff>University of LA Monroe</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Blake Salisbury declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jamie Terrell declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17636.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Antacids are a group of drugs that have been on the market for many years. They were initially first-line defense against peptic ulcer disease; however, the discovery of proton pump inhibitors revolutionized the treatment of peptic ulcer disease. Currently, antacid use is restricted to relieve mild intermittent gastroesophageal reflux disease (GERD) with associated heartburn. This activity reviews the indications, contraindications, pharmaceutical action, adverse events, and other key elements of antacid therapy in the clinical setting as relates to the essential points needed by members of an interprofessional team managing the care of patients with heartburn and mild GERD.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action antacids.</p></list-item><list-item><p>Summarize the indications for antacid therapy, including relevant interactions with other medications.</p></list-item><list-item><p>Review the potential adverse events associated with the use of antacids.</p></list-item><list-item><p>Outline the role of interprofessional coordination in guiding patient care and improving outcomes when using antacid therapy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17636&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17636">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17636.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Antacids are a group of drugs that have been on the market for many years. They were initially first-line defense against peptic ulcer disease; however, the discovery of proton pump inhibitors revolutionized the treatment of peptic ulcer disease. Currently, antacid use is restricted to relieving mild intermittent&#x000a0;gastroesophageal&#x000a0;reflux disease (GERD) associated with heartburn.<xref ref-type="bibr" rid="article-17636.r1">[1]</xref> The estimated prevalence of heartburn at least once per week in North America ranges from 18% to 28%, with 25% of adults reporting heartburn daily.<xref ref-type="bibr" rid="article-17636.r2">[2]</xref><xref ref-type="bibr" rid="article-17636.r3">[3]</xref><xref ref-type="bibr" rid="article-17636.r4">[4]</xref><xref ref-type="bibr" rid="article-17636.r5">[5]</xref></p>
        <p>Antacids&#x000a0;are medications that do not require a prescription; in other words, they are self-prescribed. Antacids are a combination of various compounds with various salts of calcium, magnesium, and aluminum&#x000a0;as active ingredients. The antacids act by neutralizing the acid in the stomach and by inhibiting pepsin, which is a proteolytic enzyme. Each of these cationic salts has a characteristic&#x000a0;pharmacological&#x000a0;property that determines its clinical use.&#x000a0;Antacids&#x000a0;have therapeutic use for&#x000a0;the following<xref ref-type="bibr" rid="article-17636.r6">[6]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Heartburn symptoms in GERD</p>
          </list-item>
          <list-item>
            <p>Duodenal and gastric ulcers</p>
          </list-item>
          <list-item>
            <p>Stress gastritis</p>
          </list-item>
          <list-item>
            <p>Pancreatic insufficiency</p>
          </list-item>
          <list-item>
            <p>Non-ulcer&#x000a0;dyspepsia</p>
          </list-item>
          <list-item>
            <p>Diarrhea caused by bile-acid</p>
          </list-item>
          <list-item>
            <p>Biliary reflux</p>
          </list-item>
          <list-item>
            <p>Constipation</p>
          </list-item>
          <list-item>
            <p>Osteoporosis</p>
          </list-item>
          <list-item>
            <p>Urinary alkalinization&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Phosphate binding in chronic renal failure</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17636.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>The antacids reduce the acid reaching the duodenum by neutralizing the acid present in the stomach. The main therapeutic objectives are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alleviating pain</p>
          </list-item>
          <list-item>
            <p>Relieving&#x000a0;pylorospasms</p>
          </list-item>
          <list-item>
            <p>Avoid digestion and corrosion by acid chyme</p>
          </list-item>
        </list>
        <p>The salts' mechanism of neutralization of acid varies, and each salt has a different mechanism with the ultimate&#x000a0;goal of acid neutralization.</p>
        <p>
<bold>Aluminum Hydroxide</bold>
</p>
        <p>The formulation of&#x000a0;aluminum hydrochloride and water results in the neutralization of the acid in the stomach. It is also known to inhibit pepsin activity.<xref ref-type="bibr" rid="article-17636.r7">[7]</xref>&#x000a0;Aluminum hydroxide is complexed with a sulfated polysaccharide&#x000a0;sucrose octasulfate to form sucralfate. This complex does not have a significant buffering action against the acid or&#x000a0;has no effect on the pepsin secretion, and does not alter the gastric acid production&#x000a0;in any way.<xref ref-type="bibr" rid="article-17636.r8">[8]</xref><xref ref-type="bibr" rid="article-17636.r9">[9]</xref>&#x000a0;Nevertheless, it is known to heal chronic ulcers and prevent acute mucosal damage induced chemically by reducing access to pepsin and acid. Sucralfate, like its aluminum&#x000a0;hydroxide component, is known to stimulate angiogenesis and granulation tissue formation.<xref ref-type="bibr" rid="article-17636.r8">[8]</xref></p>
        <p>Aluminum&#x000a0;hydroxide is also useful in hyperphosphatemia due to its&#x000a0;ability to bind phosphate in the gastrointestinal (GI) tract and subsequently prevent the absorption of phosphate.<xref ref-type="bibr" rid="article-17636.r10">[10]</xref></p>
        <p>
<bold>Calcium Salts</bold>
</p>
        <p>Calcium salts neutralize gastric acidity, resulting in increased gastric and duodenal bulb pH; they also inhibit pepsin's proteolytic activity if the pH is greater than 4 and increase lower esophageal sphincter tone. The calcium released from calcium carbonate is known to increase peristalsis in the esophagus, pushing the acid into the stomach and providing relief from heartburn symptoms. The calcium salts also form combined insoluble compounds with dietary phosphate and prevent the absorption of the latter.<xref ref-type="bibr" rid="article-17636.r11">[11]</xref></p>
        <p>The acid-neutralizing mechanism of the antacids is well understood, as mentioned above. In addition to this, other mechanisms add to the ulcer healing properties of this class of drugs.&#x000a0;The exact mechanism is still unclear, but it is believed to be a combination of<xref ref-type="bibr" rid="article-17636.r12">[12]</xref><xref ref-type="bibr" rid="article-17636.r7">[7]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ability to promote angiogenesis</p>
          </list-item>
          <list-item>
            <p>Bind to bile acids</p>
          </list-item>
          <list-item>
            <p>Inhibit peptic activity</p>
          </list-item>
          <list-item>
            <p>Suppress&#x000a0;<italic toggle="yes">Helicobacter pylori&#x000a0;</italic>growth</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17636.s4" sec-type="Administration">
        <title>Administration</title>
        <p>The dose for antacids depends upon the patient's age, the purpose of administration (neutralization of acid or off-label use), and the presence of other comorbidities like renal or hepatic impairment. As all the forms of these medications are available&#x000a0;in over-the-counter formulations, the dosing recommendation varies by product/and or manufacturer.&#x000a0;</p>
        <p>
<bold>&#x000a0;Aluminum&#x000a0;Hydroxide (Antacid)&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Oral:</italic> Usually taken daily after meals and at bedtime at a dose of&#x000a0; 640 mg up to 5 to 6 times a day with a maximum dose of 3,840 mg per 24 hours.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Suspension&#x000a0;&#x000a0;</italic>The dose for suspension form is 320 mg/5 mL (473 mL). The suspension is to be shaken before use and is to&#x000a0;be followed&#x000a0;by water.</p>
          </list-item>
        </list>
        <p>
<bold>Hyperphosphatemia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Oral:&#x000a0; Use is reserved for patients with serum phosphorus levels greater than 7 mg/dl.&#x000a0;It is to be taken with meals at a dose of 300&#x000a0; to 600 mg three times a day, with use limited to a short period (4 weeks).<xref ref-type="bibr" rid="article-17636.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Calcium Carbonate (Antacid)</bold>
</p>
        <p>It is used up to a maximum&#x000a0;dose of&#x000a0;8000 mg per day (1 to 4 tablets daily) for up to two weeks for symptomatic relief.</p>
        <p>
<bold>Hyperphosphatemia</bold>
</p>
        <p>The total dose is not to exceed 2000 mg per day.<xref ref-type="bibr" rid="article-17636.r13">[13]</xref></p>
        <p>
<bold>Pregnancy and Breastfeeding</bold>
</p>
        <p>Antacids containing aluminum salts are safe to be used in pregnant women as well as for women during labor&#x000a0;for aspiration prophylaxis. The information regarding the use of aluminum-containing antacids in breastfeeding&#x000a0;females has not been studied, but aluminum&#x000a0;is known to be endogenous to breast milk.<xref ref-type="bibr" rid="article-17636.r14">[14]</xref><xref ref-type="bibr" rid="article-17636.r15">[15]</xref>&#x000a0;In the case of calcium-containing antacids, excessive use&#x000a0;is to be avoided in pregnant women as calcium crosses the placenta. The amount of calcium reaching the fetus is dependent on the physiological changes in the mother. Maternal calcium intake also affects the amount of calcium excreted in breast milk; the currently prevailing opinion is that&#x000a0;the use of calcium-containing&#x000a0;antacids is safe during&#x000a0;breastfeeding.<xref ref-type="bibr" rid="article-17636.r16">[16]</xref></p>
      </sec>
      <sec id="article-17636.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Adverse effects are prominent in the infant and the elderly populations. The chronic use of antacids in this population is not a recommendation due to safety concerns.</p>
        <p>
<bold>Aluminum&#x000a0;Hydroxide</bold>
</p>
        <p>Aluminum use&#x000a0;is associated with an increased risk of toxicity in individuals with renal failure and infants. It presents as<xref ref-type="bibr" rid="article-17636.r17">[17]</xref><xref ref-type="bibr" rid="article-17636.r18">[18]</xref><xref ref-type="bibr" rid="article-17636.r19">[19]</xref><xref ref-type="bibr" rid="article-17636.r20">[20]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Osteopenia</p>
          </list-item>
          <list-item>
            <p>Microcytic anemia</p>
          </list-item>
          <list-item>
            <p>Neurotoxicity</p>
          </list-item>
          <list-item>
            <p>Osteomalacia</p>
          </list-item>
          <list-item>
            <p>Constipation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Fecal impaction</p>
          </list-item>
          <list-item>
            <p>Nausea</p>
          </list-item>
          <list-item>
            <p>Vomiting</p>
          </list-item>
          <list-item>
            <p>Abdominal cramps</p>
          </list-item>
          <list-item>
            <p>Hypomagnesemia</p>
          </list-item>
          <list-item>
            <p>Hypophosphatemia</p>
          </list-item>
        </list>
        <p>
<bold>Calcium Carbonate</bold>
</p>
        <p>The adverse reactions often seen with this&#x000a0; group of antacids are<xref ref-type="bibr" rid="article-17636.r20">[20]</xref><xref ref-type="bibr" rid="article-17636.r21">[21]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abdominal pain</p>
          </list-item>
          <list-item>
            <p>Anorexia</p>
          </list-item>
          <list-item>
            <p>Constipation</p>
          </list-item>
          <list-item>
            <p>Acid rebound</p>
          </list-item>
          <list-item>
            <p>Nausea</p>
          </list-item>
          <list-item>
            <p>Vomiting</p>
          </list-item>
          <list-item>
            <p>Flatulence</p>
          </list-item>
          <list-item>
            <p>Xerostomia</p>
          </list-item>
          <list-item>
            <p>Headache</p>
          </list-item>
          <list-item>
            <p>Hypercalcemia</p>
          </list-item>
          <list-item>
            <p>Hypophosphatemia</p>
          </list-item>
          <list-item>
            <p>Milk-alkali syndrome</p>
          </list-item>
        </list>
        <p>Antacids can exhibit clinically significant interactions with other medication a patient may be taking.<xref ref-type="bibr" rid="article-17636.r22">[22]</xref>&#x000a0;Some examples include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Using&#x000a0;antacids&#x000a0;concomitantly&#x000a0;with acidic drugs (e.g., digoxin, chlorpromazine isoniazid)&#x000a0;can&#x000a0;result in impaired absorption of these&#x000a0;acidic drugs,&#x000a0;reducing the&#x000a0;blood concentrations of the drugs&#x000a0;and impairing their therapeutic effects.</p>
          </list-item>
          <list-item>
            <p>Concurrent antacid use with&#x000a0;some drugs (e.g., pseudoephedrine, levodopa)&#x000a0;can result in&#x000a0;increased absorption of the drugs, leading to potential toxicity or&#x000a0;adverse events from increased serum concentration of these drugs.</p>
          </list-item>
          <list-item>
            <p>Antacids&#x000a0;containing magnesium trisilicate and magnesium hydroxide can bind to drugs like tetracycline and fluoroquinolone antibiotics, impeding&#x000a0;their absorption and therapeutic effects.</p>
          </list-item>
          <list-item>
            <p>Sodium bicarbonate significantly affects&#x000a0;urine acidity, which can&#x000a0;alter&#x000a0;the renal elimination of some drugs by the kidney; sodium bicarbonate inhibits the excretion of basic drugs such as amphetamines and quinidine&#x000a0;while increasing&#x000a0;the excretion of acidic drugs&#x000a0;like aspirin.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17636.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The absolute contraindication is hypersensitivity to any component of the formulation.&#x000a0;Also, antacid agents require caution in patients with:</p>
        <list list-type="bullet">
          <list-item>
            <p>Renal&#x000a0; failure</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Edema&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cirrhosis</p>
          </list-item>
          <list-item>
            <p>Low-sodium diets</p>
          </list-item>
          <list-item>
            <p>Uremia</p>
          </list-item>
          <list-item>
            <p>GI hemorrhages</p>
          </list-item>
          <list-item>
            <p>Hyperparathyroidism</p>
          </list-item>
          <list-item>
            <p>Renal calculus</p>
          </list-item>
          <list-item>
            <p>Achlorhydria</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17636.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>The average therapeutic dose of antacid is 10 to 15 mL (1 tablespoon or one package content) of liquid or 1 to 2 tablets 3 to 4 times a day. Periodic monitoring of calcium and phosphorus plasma concentrations is a suggested practice in patients on chronic therapy.</p>
      </sec>
      <sec id="article-17636.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>No information is available&#x000a0;regarding toxicities caused by aluminum- and calcium-containing&#x000a0;antacids. However, antacids are to be used cautiously in the high-risk population mentioned above.</p>
      </sec>
      <sec id="article-17636.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Antacids are available as over-the-counter medications, meaning that patients do not require a prescription to obtain them. These medications only provide symptomatic relief, which may mask an underlying disorder, but lack of awareness in this regard may delay the diagnosis in health conditions like GERD, peptic ulcer, gastric ulcer, and hiatal hernia. This situation results in the improper use of these medications with little to no relief of symptoms. There is a need to educate patients regarding the importance of a correct mode of administration, time of administration, and dosage for the prompt and prolonged relief of symptoms. Although these medications do not cause toxicities in high doses, it is imperative to understand their interaction with other medicines, especially in patients&#x000a0;engaged in polypharmacy.<xref ref-type="bibr" rid="article-17636.r23">[23]</xref></p>
        <p>Nursing can verify drug use on intake and at each exam and report to the treating clinician. Pharmacists will encounter patients in the retail pharmacy and can counsel and educate patients on the advantages and pitfalls of antacid therapy and inform the patient's treating physician if there are any issues (drug-drug interactions, for example). Even a medication as apparently benign as OTC antacids can significantly affect patient health, and the interprofessional team needs to work together and communicate to achieve positive outcomes. [Level 5]</p>
      </sec>
      <sec id="article-17636.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17636&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17636">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17636/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17636">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17636.s11">
        <title>References</title>
        <ref id="article-17636.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sontag</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>The medical management of reflux esophagitis. Role of antacids and acid inhibition.</article-title>
            <source>Gastroenterol Clin North Am</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>683</fpage>
            <page-range>683-712</page-range>
            <pub-id pub-id-type="pmid">1977703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Serag</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Sweet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Winchester</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Dent</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.</article-title>
            <source>Gut</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>871</fpage>
            <page-range>871-80</page-range>
            <pub-id pub-id-type="pmid">23853213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moayyedi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Axon</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Review article: gastro-oesophageal reflux disease--the extent of the problem.</article-title>
            <source>Aliment Pharmacol Ther</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>22 Suppl 1</volume>
            <fpage>11</fpage>
            <page-range>11-9</page-range>
            <pub-id pub-id-type="pmid">16042655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Castell</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Spechler</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>98</volume>
            <issue>7</issue>
            <fpage>1487</fpage>
            <page-range>1487-93</page-range>
            <pub-id pub-id-type="pmid">12873567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisen</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of gastroesophageal reflux disease: what we know and what we need to know.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>96</volume>
            <issue>8 Suppl</issue>
            <fpage>S16</fpage>
            <page-range>S16-8</page-range>
            <pub-id pub-id-type="pmid">11510763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maton</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.</article-title>
            <source>Drugs</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>855</fpage>
            <page-range>855-70</page-range>
            <pub-id pub-id-type="pmid">10400401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berstad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Berstad</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute effects of antacids on gastric juice components in duodenal ulcer patients.</article-title>
            <source>Eur J Clin Invest</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>511</fpage>
            <page-range>511-5</page-range>
            <pub-id pub-id-type="pmid">2124982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarnawski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanoue</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sarfeh</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment?</article-title>
            <source>Scand J Gastroenterol Suppl</source>
            <year>1995</year>
            <volume>210</volume>
            <fpage>9</fpage>
            <page-range>9-14</page-range>
            <pub-id pub-id-type="pmid">8578218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soll</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Kurata</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Nonsteroidal anti-inflammatory drugs and peptic ulcer disease.</article-title>
            <source>Ann Intern Med</source>
            <year>1991</year>
            <month>Feb</month>
            <day>15</day>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>307</fpage>
            <page-range>307-19</page-range>
            <pub-id pub-id-type="pmid">1987878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schucker</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Hyperphosphatemia and phosphate binders.</article-title>
            <source>Am J Health Syst Pharm</source>
            <year>2005</year>
            <month>Nov</month>
            <day>15</day>
            <volume>62</volume>
            <issue>22</issue>
            <fpage>2355</fpage>
            <page-range>2355-61</page-range>
            <pub-id pub-id-type="pmid">16278327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Stanley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zubaidi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akbarali</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Mellow</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Miner</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Calcium carbonate antacids alter esophageal motility in heartburn sufferers.</article-title>
            <source>Dig Dis Sci</source>
            <year>2004</year>
            <season>Nov-Dec</season>
            <volume>49</volume>
            <issue>11-12</issue>
            <fpage>1862</fpage>
            <page-range>1862-7</page-range>
            <pub-id pub-id-type="pmid">15628717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarnawski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hollander</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gergely</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Antacids: new perspectives in cytoprotection.</article-title>
            <source>Scand J Gastroenterol Suppl</source>
            <year>1990</year>
            <volume>174</volume>
            <fpage>9</fpage>
            <page-range>9-14</page-range>
            <pub-id pub-id-type="pmid">2205902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <collab>National Kidney Foundation</collab>
            <article-title>K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>4 Suppl 3</issue>
            <fpage>S1</fpage>
            <page-range>S1-201</page-range>
            <pub-id pub-id-type="pmid">14520607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chao</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Hsiung</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>YK</given-names>
              </name>
            </person-group>
            <article-title>Arsenic, cadmium, lead, and aluminium concentrations in human milk at early stages of lactation.</article-title>
            <source>Pediatr Neonatol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-34</page-range>
            <pub-id pub-id-type="pmid">24231114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fanni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ambu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gerosa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nemolato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iacovidou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Van Eyken</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fanos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Zaffanello</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Faa</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods.</article-title>
            <source>World J Pediatr</source>
            <year>2014</year>
            <month>May</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-7</page-range>
            <pub-id pub-id-type="pmid">24801228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahadevan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy.</article-title>
            <source>Gastroenterology</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>278</fpage>
            <page-range>278-82</page-range>
            <pub-id pub-id-type="pmid">16831610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsou</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Vanderhoof</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum.</article-title>
            <source>Pediatrics</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>148</fpage>
            <page-range>148-51</page-range>
            <pub-id pub-id-type="pmid">1987526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodard-Knight</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fudge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Teubner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simmer</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Aluminium absorption and antacid therapy in infancy.</article-title>
            <source>J Paediatr Child Health</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>257</fpage>
            <page-range>257-9</page-range>
            <pub-id pub-id-type="pmid">1605980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sedman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Aluminum toxicity in childhood.</article-title>
            <source>Pediatr Nephrol</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>383</fpage>
            <page-range>383-93</page-range>
            <pub-id pub-id-type="pmid">1498007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Casavant</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nahata</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mahan</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Metabolic bone disease after chronic antacid administration in an infant.</article-title>
            <source>Ann Pharmacother</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>265</fpage>
            <page-range>265-8</page-range>
            <pub-id pub-id-type="pmid">14742764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pivnick</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Chesney</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Rickets secondary to phosphate depletion. A sequela of antacid use in infancy.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-8</page-range>
            <pub-id pub-id-type="pmid">7729110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walden</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Khotimchenko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chakravarty</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Varshney</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study.</article-title>
            <source>Pharmaceutics</source>
            <year>2021</year>
            <month>Apr</month>
            <day>21</day>
            <volume>13</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33919271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17636.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khandeparkar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rataboli</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.</article-title>
            <source>Perspect Clin Res</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>180</fpage>
            <page-range>180-186</page-range>
            <pub-id pub-id-type="pmid">29109936</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
